The Northeast Node was awarded a new CTN study: CTN-0116
December 4, 2020
The Northeast Node was awarded a new CTN study: Pharmacist-Integrated Model of Medication Treatment for Opioid Use Disorder.
Pharmacists remain an underutilized resource in the treatment of opioid use disorder (OUD). Although studies have engaged pharmacists in dispensing medications in OUD treatment (MOUD), few studies have evaluated collaborative care models in which pharmacists are an active, integral part of a primary care team offering OUD care. In this Phase 1 project, we seek to leverage a promising model of pharmacist-integrated care for OUD to 1) employ a mixed methods approach to evaluate the feasibility and acceptability of implementing a pharmacist-integrated model of MOUD into the clinical workflow of a diverse array of clinical sites and 2) evaluate the impact of the pharmacist-integrated model on the clinical sites’ capacity for MOUD care and on patient engagement in OUD care.
Principle Investigator: Lisa A. Marsch, PhD, Northeast Node, Geisel School of Medicine, Dartmouth College
Co-Lead Investigators: Felicity Homsted, PharmD, MBA; Northeast Node; David Fiellin, MD, New England Consortium
Other Team Members: Paul Joudrey, MD, MPH, New England Consortium; Noah Nesin, MD, Penobscot Community Health Care (PCHC); Trip Gardner, MD, PCHC; Kristopher Ravin, PharmD, PCHC; Vijay Amarendran, MD, PCHC; Frank McGrady, PharmD, BCPS, PCHC; Melissa Carr, RPh, PCHC; Alison Carter, PCHC; Sharyl White, BA, MCP, PCHC; Dustin Corey, PCHC; Robert Zavaleta, PCHC; Lisa Saldana, PhD, Oregon Social Learning Center; Sarah Moore, PhD, Northeast Node, Udi Ghitza, PhD, Bethany McLeman, BA, Project Director, Northeast Node; Laurie Lester, PhD, Project Manager, Northeast Node; Phoebe Gauthier, MA, MPH, Regulatory Manager, Northeast Node